128 related articles for article (PubMed ID: 18208798)
1. The MonoPrep Pap test for the detection of cervical cancer and its precursors. Part I: results of a multicenter clinical trial.
Cibas ES; Alonzo TA; Austin RM; Bolick DR; Glant MD; Henry MR; Moriarty AT; Molina JT; Rushing L; Slowman SD; Torno R; Eisenhut CC
Am J Clin Pathol; 2008 Feb; 129(2):193-201. PubMed ID: 18208798
[TBL] [Abstract][Full Text] [Related]
2. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
4. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results.
Bishop JW; Bigner SH; Colgan TJ; Husain M; Howell LP; McIntosh KM; Taylor DA; Sadeghi MH
Acta Cytol; 1998; 42(1):189-97. PubMed ID: 9479339
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
[TBL] [Abstract][Full Text] [Related]
6. CytoRich liquid-based cervical cytologic test. Screening results in a routine cytopathology service.
Vassilakos P; Griffin S; Megevand E; Campana A
Acta Cytol; 1998; 42(1):198-202. PubMed ID: 9479340
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cellular residue in the ThinPrep PreservCyt vial.
Massarani-Wafai R; Bakhos R; Wojcik EM; Selvaggi SM
Diagn Cytopathol; 2000 Sep; 23(3):208-12. PubMed ID: 10945912
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
Papillo JL; Zarka MA; St John TL
Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
[TBL] [Abstract][Full Text] [Related]
9. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
10. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
11. The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.
Rosenthal DL; Geddes S; Trimble CL; Carson KA; Alli PM
Cancer; 2006 Jun; 108(3):137-43. PubMed ID: 16628656
[TBL] [Abstract][Full Text] [Related]
12. Digital holographic microscopy as screening tool for cervical cancer preliminary study.
Benzerdjeb N; Garbar C; Camparo P; Sevestre H
Cancer Cytopathol; 2016 Aug; 124(8):573-80. PubMed ID: 27136615
[TBL] [Abstract][Full Text] [Related]
13. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears.
Negri G; Menia E; Egarter-Vigl E; Vittadello F; Mian C
Cancer; 2003 Dec; 99(6):342-5. PubMed ID: 14681941
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of unsatisfactory conventional pap smears owing to inadequate squamous cellularity defined by the Bethesda 2001 criterion.
Adams AL; Gidley J; Roberson J; Wang W; Eltoum I; Chhieng DC
Am J Clin Pathol; 2005 May; 123(5):738-43. PubMed ID: 15981813
[TBL] [Abstract][Full Text] [Related]
15. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
16. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients.
Patton AL; Duncan L; Bloom L; Phaneuf G; Zafar N
Cancer; 2008 Dec; 114(6):481-8. PubMed ID: 18980288
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
18. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
Huitron S; Bonvicino A; Fadare O
Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
[TBL] [Abstract][Full Text] [Related]
19. Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored.
Barreth D; Schepansky A; Capstick V; Johnson G; Steed H; Faught W
J Obstet Gynaecol Can; 2006 Dec; 28(12):1095-1098. PubMed ID: 17169233
[TBL] [Abstract][Full Text] [Related]
20. The ThinPrep Pap test. A review of clinical studies.
Linder J; Zahniser D
Acta Cytol; 1997; 41(1):30-8. PubMed ID: 9022723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
